139 related articles for article (PubMed ID: 20047135)
21. Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial.
Braun MS; Richman SD; Thompson L; Daly CL; Meade AM; Adlard JW; Allan JM; Parmar MK; Quirke P; Seymour MT
J Clin Oncol; 2009 Nov; 27(33):5519-28. PubMed ID: 19858398
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?
Fariña Sarasqueta A; van Lijnschoten G; Lemmens VE; Rutten HJ; van den Brule AJ
Mol Diagn Ther; 2011 Oct; 15(5):277-83. PubMed ID: 21958378
[TBL] [Abstract][Full Text] [Related]
23. The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China.
Ge J; Tian AX; Wang QS; Kong PZ; Yu Y; Li XQ; Cao XC; Feng YM
PLoS One; 2013; 8(6):e67589. PubMed ID: 23826324
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.
Lv H; Li Q; Qiu W; Xiang J; Wei H; Liang H; Sui A; Liang J
Cancer Invest; 2013 Jan; 31(1):24-8. PubMed ID: 23327191
[TBL] [Abstract][Full Text] [Related]
26. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
Booton R; Ward T; Heighway J; Ashcroft L; Morris J; Thatcher N
J Thorac Oncol; 2006 Sep; 1(7):679-83. PubMed ID: 17409936
[TBL] [Abstract][Full Text] [Related]
27. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
29. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.
Zhong SL; Zhou SF; Chen X; Chan SY; Chan E; Ng KY; Duan W; Huang M
Eur J Pharm Sci; 2006 May; 28(1-2):77-85. PubMed ID: 16488119
[TBL] [Abstract][Full Text] [Related]
30. Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.
Zarate R; Rodríguez J; Bandres E; Patiño-Garcia A; Ponz-Sarvise M; Viudez A; Ramirez N; Bitarte N; Chopitea A; Gacía-Foncillas J
Br J Cancer; 2010 Mar; 102(6):987-94. PubMed ID: 20216541
[TBL] [Abstract][Full Text] [Related]
31. XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.
Ye F; Liu Z; Tan A; Liao M; Mo Z; Yang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):733-40. PubMed ID: 23299794
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
[TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase gene polymorphisms and risk of nasal or colorectal polyposis.
Zhang Y; Zhang H; Lin P; Zhang G
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30617052
[TBL] [Abstract][Full Text] [Related]
34. Association of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patients.
Vekic J; Zeljkovic A; Jelic-Ivanovic Z; Damjanovic T; Suvakov S; Matic M; Savic-Radojevic A; Simic T; Spasojevic-Kalimanovska V; Gojkovic T; Spasic S; Dimkovic N
Clin Biochem; 2014 Apr; 47(6):398-403. PubMed ID: 24291050
[TBL] [Abstract][Full Text] [Related]
35. Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients.
Jones BA; Christensen AR; Wise JP; Yu H
Cancer Epidemiol; 2009 Oct; 33(3-4):249-56. PubMed ID: 19748847
[TBL] [Abstract][Full Text] [Related]
36. Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.
Ott K; Lordick F; Becker K; Ulm K; Siewert J; Höfler H; Keller G
Int J Colorectal Dis; 2008 Aug; 23(8):773-82. PubMed ID: 18443805
[TBL] [Abstract][Full Text] [Related]
37. Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy.
Yokomizo A; Yamamoto K; Kinukawa N; Tsunoda T; Koga H; Naito S
Int J Urol; 2007 Jun; 14(6):500-4. PubMed ID: 17593093
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin.
Kap EJ; Richter S; Rudolph A; Jansen L; Ulrich A; Hoffmeister M; Ulrich CM; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2014 Jul; 24(7):340-7. PubMed ID: 24842074
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.
Goekkurt E; Hoehn S; Wolschke C; Wittmer C; Stueber C; Hossfeld DK; Stoehlmacher J
Br J Cancer; 2006 Jan; 94(2):281-6. PubMed ID: 16317430
[TBL] [Abstract][Full Text] [Related]
40. Glutathione S-transferase P1 Ile105Val polymorphism is associated with haematological toxicity in elderly rectal cancer patients receiving preoperative chemoradiotherapy.
Agostini M; Pasetto LM; Pucciarelli S; Terrazzino S; Ambrosi A; Bedin C; Galdi F; Friso ML; Mescoli C; Urso E; Leon A; Lise M; Nitti D
Drugs Aging; 2008; 25(6):531-9. PubMed ID: 18540691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
